Navigation Links
Martin Durant Promoted to Executive Vice President and Deputy CFO; Sue Blanck Promoted to First Senior Vice President of Aflac Japan
Date:6/1/2008

COLUMBUS, Ga., June 1 /PRNewswire-FirstCall/ -- Aflac Incorporated announced today that Martin A. Durant III has been promoted to executive vice president and deputy chief financial officer. Susan R. Blanck has been promoted to first senior vice president of Aflac Japan. Both promotions are effective June 1, 2008.

Durant first joined Aflac in 1990 as vice president and comptroller of Aflac Incorporated. He was with Aflac for 10 years, eventually serving as senior vice president of Corporate Services. In 1999, he accepted a position with Carmike Cinemas, Inc. as senior vice president and chief financial officer. Following his retirement from Carmike, Durant rejoined Aflac in July 2006 as senior vice president of Corporate Finance. In his new position of deputy CFO, he will continue to work closely with Aflac Incorporated president and chief financial officer, Kriss Cloninger III, on capital management, risk management and other financial matters.

Blanck joined Aflac's Actuarial Department in 1993 in the U.S. pricing area. She was named senior vice president and deputy corporate actuary in March 2004 and was promoted to corporate actuary in January 2006. She will continue in her capacity as senior vice president and corporate actuary, reporting to Martin Durant. In her new position as first senior vice president of Aflac Japan, she will report to Tohru Tonoike, president of Aflac Japan, and she will continue her work in Aflac Japan's product development area as well as other strategic marketing initiatives.

Commenting on the announcement, Aflac Chairman and Chief Executive Officer Daniel P. Amos said: "I'm very pleased to announce the promotions of these two deserving individuals and valuable members of our management team. Martin has certainly earned this recognition and is a tremendous asset to Aflac. In addition to Sue's responsibility of leading our global actuarial staff, she has spent an increasing amount of time on Aflac Japan market
'/>"/>

SOURCE Aflac Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Purple: The Hottest Color for Fall in Shoes, Handbags and Martinis
2. DRAXIS Health Inc. Announces Retirement of Dr. Martin Barkin as President and Chief Executive Officer
3. Eric Rowinsky, M.D. and Martin Cannon Join Tapestry Board of Directors
4. Joe Martin Appointed CEO of Milestone Scientific and New Executive Member of the Board of Directors
5. Representative Greg Harris, Senator Jacqueline Collins, Senator Iris Martinez and Fellow State Legislators to Join Susan G. Komen for the Cure in Announcing Groundbreaking Legislation to Reduce Breast Cancer Disparities; Will Hold Press Conference Friday
6. Ronnie B. Martin, DO, FACOFP-dist. to be Inaugurated as the 55th President of the ACOFP (2008-2009)
7. Lockheed Martin Agrees to Acquire Eagle Group International, LLC
8. Fletcher Martin Creates Interactive Game-Ad for BioLab(R) UV for BioGuard(R)
9. Lockheed Martin Completes Acquisition of Eagle Group International, LLC
10. Ricki Lakes New Movie, The Business of Being Born Promoted by Local Mom-Roots Campaign
11. Aviva Belsky Promoted to Publisher of Contemporary Surgery

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ntists may not be able to tell a good book by its ...ld book by its smell. In a report in ACS, Analyti...ibe development of a new test that can measure the...documents based on their smell. The nondestructive...serve a range of prized paper-based objects, some ...
(Date:12/2/2009)...ampions Biotechnology, Inc. (OTC Bulletin Board: C...h a predictive preclinical platform aimed at accel... oncology drugs, has established an exclusive lice...Ltd., Tel Aviv University,s wholly owned technolog...ncompasses the development and commercialization o...
(Date:12/2/2009)... MyCareTeam, Inc., a leading vend...ftware, has released the newest version of its sof...rtension, congestive heart failure and weight mana...abetes monitoring features. , ...reTeam, Inc., a leading vendor of Internet-based c...
(Date:12/2/2009)... , ARLINGTON, Va., Dec. 2 Fro...life that give us meaning, joy and peace, the LIFE...ever contest conducted using the popular photo-sha...e viewed in a video montage on the LIFE Foundation.... ,, Contestants submitted one photo and a cap...
(Date:12/2/2009)... , MORRISTOWN, N.J., Dec. 2 /PRNewswire-FirstCa... today announced that the Federal Trade Commission...ublic comment relating to Watson,s pending acquisi... early termination of the Hart Scott Rodino waitin...the transaction. The parties have now obtained al...
Breaking Medicine News(10 mins):Health News:Champions Biotechnology signs exclusive agreement with Tel Aviv University for cancer drug 2Health News:MyCareTeam™ Significantly Extends Diabetes Offering to Include Management of Hypertension, Obesity, and Congestive Heart Failure 2Health News:Wonders of Life Photo Contest Winners Announced 2Health News:Wonders of Life Photo Contest Winners Announced 3Health News:Watson Receives FTC Clearance for Arrow Acquisition 2
...POLIS, Dec. 8 A mural on a 1,230-foot-long wall,a...Indianapolis, has achieved,recognition as a new Gu...fication projects completed in partnership with Ke...ld last May. , Lilly and KIB submitted the m...
...LE, Calif., Dec. 8 Expresso Fitness(R), the leadi...tness systems, announced today,that it has complet...$14M.,The capital will be used to fuel Expresso,s ...xpresso. The equity round was,joined by all exist...
...EE, Dec. 8 Aurora Health Care and Associated Surg...premier ambulatory surgery centers, announced toda... the two organizations jointly operate the surgery...nce the quality of care for patients," said James ...
...rts are recommending that a malaria vaccine progre...l of the RTS, S/AS01E malaria vaccine among 5-17 m... Kenya, which is reported today in the New Englan...inistration of the RTS, S/AS02 malaria vaccine thr...
..., Dec. 8 Americans United for Life (AUL) condemns...e state have a right to die by assisted suicide, a...ontana State Supreme Court. , , Dr. Charmai...ses in Oregon where patients are denied state insu...
...ic Injury Protection Program Expands Benefits , ...s Affairs (VA) announced some severely injured mil...improvements to the Servicemembers, Group Life Ins...y personnel and their families," said Secretary of...
Other Medicine News:Health News:Lilly Global Day of Service Receives National and Local Recognition 2Health News:Lilly Global Day of Service Receives National and Local Recognition 3Health News:Expresso Fitness(R) Receives Additional $14 Million in Funding 2Health News:Expresso Fitness(R) Receives Additional $14 Million in Funding 3Health News:Expresso Fitness(R) Receives Additional $14 Million in Funding 4Health News:Aurora and Associated Surgical & Medical Specialists Announce Surgery Center Joint Venture 2Health News:Promising trials of malaria vaccine lead to calls for Phase 3 development 2Health News:Promising trials of malaria vaccine lead to calls for Phase 3 development 3Health News:Americans United For Life Denounces Montana Court's Assisted Suicide Decision, Urges Appeal 2Health News:VA Announces Changes to Servicemembers' Group Life Insurance 2
(Date:12/2/2009)... and NEW YORK, Dec. 2 In...U Langone Medical Center announced findings from a...sity on the genetics of osteoarthritis have been p...f the Annals of Rheumatic Diseases and is availabl...043v1.pdf . Results from the study highlight i...
(Date:12/2/2009)...Dec. 2 Novavax, Inc. (Na...ults from the first stage of a two-stage pivotal P...city of the company,s 2009 H1N1 virus-like particl...nducting this study in collaboration with Avimex L...he vaccine in Mexico and potentially other countri...
(Date:12/2/2009)..., Dec. 2 Adults are more likely .... For adults 65 and over, the odds of losing visio...loping prostate cancer are one in six and odds of ... Vision loss threatens the overall health of aging...sion and inability to complete daily tasks. ,, ...
Breaking Medicine Technology:Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 2Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 3Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 4NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 2NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 3NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 4Risk of Vision Loss in Aging Adults is Greater Than Risk of Breast or Prostate Cancer 2Respiratory Issues Linger for Smallest Babies 51318 1Respiratory Issues Linger for Smallest Babies 51318 2More Mammograms May Mean More Harmless Cancers 51316 1More Mammograms May Mean More Harmless Cancers 51316 2NMB Expands in Canada 51314 1NMB Expands in Canada 51314 2
...o be Presented at Lymphoma Meeting in Lugano, Swit...el,today reported an abstract providing preliminar...Syk inhibitor, R788 (fostamatinib disodium), in,pa...kin,s lymphomas (NHL).,The abstract reports favora...mphocytic lymphoma/chronic lymphocytic leukemia (S...
... FRANCISCO, Calif., June 2 Rigel,Pharmaceuticals,...l host a,conference call with simultaneous webcast... clinical study of R788, a novel, oral Syk kinase,...ymphomas on Tuesday, June,3, 2008 at 8:00 a.m. EDT...anagement and the principal investigator on the st...
Other Medicine Technology:Preliminary Phase 2 Results of R788 in Lymphoma Show Benefit in Diffuse Large B-Cell and SLL/CLL 2Preliminary Phase 2 Results of R788 in Lymphoma Show Benefit in Diffuse Large B-Cell and SLL/CLL 3Preliminary Phase 2 Results of R788 in Lymphoma Show Benefit in Diffuse Large B-Cell and SLL/CLL 4Rigel to Host Conference Call to Discuss Preliminary Phase 2 Study Results of R788 in Lymphoma 2
Orrison's Medical Imaging Consultant for PDA
Schwartz Principles of Surgery PDA Edition
Sanford Guide to HIV/AIDS Therapy 2004
LyteMeister
Medicine Products: